Related references
Note: Only part of the references are listed.CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus
Yong Suk Cho et al.
GENES & DEVELOPMENT (2020)
Cdk7: a kinase at the core of transcription and in the crosshairs of cancer drug discovery
Robert P. Fisher
TRANSCRIPTION-AUSTIN (2019)
YAP and TAZ: a signalling hub of the tumour microenvironment
Francesca Zanconato et al.
NATURE REVIEWS CANCER (2019)
YAP/TAZ upstream signals and downstream responses
Antonio Totaro et al.
NATURE CELL BIOLOGY (2018)
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
Francesca Zanconato et al.
NATURE MEDICINE (2018)
The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ
Lei Chang et al.
NATURE (2018)
Transcriptional Addiction in Cancer
James E. Bradner et al.
CELL (2017)
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
Yubao Wang et al.
CELL (2015)
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Junwei Shi et al.
MOLECULAR CELL (2014)
Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
Dawang Zhou et al.
CANCER CELL (2009)
Share Paper
